16th Apr 2021 11:00
16 April 2021
Benchmark Holdings
("Benchmark" or the "Company")
BMK08+CleanTreatÒ Update
Ratification of Maximum Residue Limit under European Law
Significant milestone towards the commercialisation of BMK08 and CleanTreatÒ
Further to the notification made on 10 September 2020, Benchmark Holdings is pleased to announce that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has now been ratified under European Law. The MRL confirms the safety of Benchmark's sea lice solution for consumers and represents a significant milestone in the regulatory approval process towards the anticipated commercial launch of BMK08 and CleanTreatÒ in Norway. The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.
BMK08 and CleanTreatÒ is a transformational solution addressing the biggest biological challenge in salmon farming. The MRL EU ratification is the culmination of almost a decade of research and development, a rigorous trial programme and substantial capital investment by Benchmark.
Trond Williksen, CEO, commented:
"The ratification of the MRL is a further stepping stone towards commercialisation following the announcement of our first customer agreements for CleanTreatâ announced in March.
Sea lice continues to be the biggest biological challenge for salmon producers and Benchmark's novel solution addresses this challenge in a sustainable way both in terms of animal welfare and environmental impact."
Enquiries:
Benchmark Holdings plc | Tel: 020 3696 0630 |
Ivonne Cantu, Investor Relations Director |
|
Rachel Aninakwah, Communications |
|
|
|
Numis (Broker and NOMAD) | Tel: 020 7260 1000 |
James Black / Freddie Barnfield / Duncan Monteith |
|
|
|
MHP |
|
Katie Hunt /Alistair de Kare-Silver | Tel: 020 3128 8742
|
About Benchmark
Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.
We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com
Related Shares:
Benchmark Holdings